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Abstract
Background: Breast cancer is one of the most common cancer types. Due to the complexity of this disease, it is 
important to face its study with an integrated and multilevel approach, from genes, transcripts and proteins to 
molecular networks, cell populations and tissues. According to the systems biology perspective, the biological 
functions arise from complex networks: in this context, concepts like molecular pathways, protein-protein interactions 
(PPIs), mathematical models and ontologies play an important role for dissecting such complexity.
Results: In this work we present the Genes-to-Systems Breast Cancer (G2SBC) Database, a resource which integrates 
data about genes, transcripts and proteins reported in literature as altered in breast cancer cells. Beside the data 
integration, we provide an ontology based query system and analysis tools related to intracellular pathways, PPIs, 
protein structure and systems modelling, in order to facilitate the study of breast cancer using a multilevel perspective. 
The resource is available at the URL http://www.itb.cnr.it/breastcancer.
Conclusions: The G2SBC Database represents a systems biology oriented data integration approach devoted to breast 
cancer. By means of the analysis capabilities provided by the web interface, it is possible to overcome the limits of 
reductionist resources, enabling predictions that can lead to new experiments.
Background
Cancer is a complex disease in which both genomic and
environmental factors affect the functioning of the
molecular circuits leading to the so-called acquired capa-
bilities of cancer [1]. Due to its complexity, it is important
to face the study of cancer exploiting an integrated and
multilevel approach, ranging from genes, transcripts and
proteins found altered in cancer cells, to whole biological
systems, represented by molecular pathways and cell
populations. The study of complex systems in biology is
addressed by systems biology, which is providing new
opportunities in cancer research [2]. Suitable examples
are the study of regulatory and signal transduction net-
works, mostly affected by genomic mutations leading to
cancer, and the analysis of cell populations dynamics.
To realise a multilevel and systems oriented approach
about a disease, it is crucial to collect and integrate data
stored in several dedicated resources. Currently, this pro-
cess is characterised by some issues. First, data required
to realise this perspective are still sparse on the web:
despite some existing databases (such as those developed
by the NCBI and the EBI) collect data from several proj-
ects, data provided by specific resources dedicated to
particular pathologies are not yet integrated and there-
fore are difficult to exploit. Moreover, the accessible
information is by far too heterogeneous: for example,
some resources make their content available relying on
identifiers that do not match directly. Another issue con-
cerns the relevance of data produced by using high-
throughput technologies, which represent a useful source
of information and, therefore, are essential in a data inte-
gration approach: this is the case, for instance, of protein-
protein interactions (PPIs) data, that enable the study of
cellular networks structure by means of graph theory
approaches. Lastly, even if several mathematical models
have been developed in the cancer research field, many of
them are not coded in standard languages and thus they
are not directly available for simulations. In this systems
biology perspective, we chose to focus our research on
one of the most common cancer types, the breast cancer,
which has a high impact on the population and is studied
within our institute (see, for instance, [3-5]).
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Generic as well as scientifically relevant resources exist
concerning this pathology. "Oncomine" [6] was developed
for cancer gene expression analysis; "The Tumour Gene
Family of Databases" [7] contains information about
genes which are targets for cancer-causing mutations; the
"BreastCancerDatabase" [8] collects molecular alterations
associated with breast cancer; the "Breast Cancer Infor-
mation Core Database" [9] stores mutations of main
breast cancer genes. However, the scientific community
lacks easily accessible data dealing with breast cancer in a
multilevel context, including molecules, molecular net-
works, cells and tissues.
To fill this gap we developed the Genes-to-Systems
Breast Cancer (G2SBC) Database. This resource realises
the integration of information concerning molecular
components related to breast cancer and the overlying
molecular and cellular layers, even providing a series of
tools for the analysis of the available data.
Construction and Content
The G2SBC Database relies on a MySQL server. The
database structure follows a data warehouse approach,
which consists in collecting and formatting heteroge-
neous data from different sources, in order to make them
accessible by the scientific community through a unified
query schema using a web interface. This approach is typ-
ical of data integration, while normalised databases,
designed to support data integrity, are widely used to
maintain primary resources. From the data integration
point of view, a series of perl scripts have been developed
to retrieve different datasets from remote and sparse data
sources. The architecture of the G2SBC Database is illus-
trated in Figure 1. The G2SBC Database maintains data
about genes, transcripts, proteins, molecular and cellular
systems, and mathematical models related to the breast
cancer pathology. The associations between genes and
breast cancer is supported by a number of molecular evi-
dences derived from literature: we refer to genes having at
least one evidence as "breast cancer genes" and to pro-
teins as "breast cancer proteins". Currently, the G2SBC
Database provides literature based evidences of molecu-
lar alterations for more than 2000 human genes. Each
molecular alteration is reported along with a reference to
the paper in which the experimental identification is
described. The complete list of molecular alterations con-
sidered at genome, transcriptome and proteome levels is
reported in Table 1. Note that the G2SBC Database con-
tains data about all the human genes, since such knowl-
edge is required to perform the analyses provided by the
tools available through the web interface, e.g. the tools
based on the PPIs.
Data has been retrieved from literature, both relying on
a manual curation process and exploiting automated
methods for data integration from datasets available on
the web [8,10-22].
Molecular components data
Breast cancer genes are annotated by gene symbol,
description, aliases and sequences. The list of molecular
alterations found in breast cancer spans the genome,
transcriptome and proteome layers and comes from both
clinical data and cell line experiments. Gene characterisa-
tion is enriched with information about the related Single
Nucleotide Polymorphisms (SNPs), downloaded from
dbSNP [10]. SNPs are ordered according to their distribu-
tion along the gene and polymorphisms occurring within
exons are highlighted in order to allow the structural
modelling of the resulting protein.
Gene products have been collected as list of mRNAs
sequences and related protein isoforms according to the
NCBI RefSeq annotations (NCBI Nucleotide [10]). Gene
expression information is supported by a link towards the
Gene Expression Atlas [14] report, where the over/under
expression of the current gene in a set of conditions
(including different diseases) is listed. Moreover, infor-
mation about expression profiles similarity has been col-
lected from a study of co-expression analysis [5], which
focused on a dataset of breast primary tumours derived
from the Stanford Microarray Database [15]. Each gene is
also associated with a list of microRNAs (microRNA.org
[22]) which target the gene transcripts.
Data about proteins include all the identifiers suitable
to download the related sequences, functional domains
according to InterPro [12], structural models from the
Protein Data Bank (PDB) [13] and drugs available to
affect their function [8]. Moreover, tissue images, show-
ing the expression and the localisation of proteins in a
large variety of human breast tissues, have been collected
from the Human Protein Atlas (HPA) [21]. This section
maintains images obtained in different conditions of
breast organ (normal breast, ductal breast cancer, lobular
in situ breast cancer, lobular breast cancer, malignant
neoplasy, hyperplasia). Each image is associated with
information concerning the protein detected on the tis-
sue, its spatial localisation (nuclei or cytoplasm/mem-
brane), some patients clinical information, staining
intensity (negative, weak, moderate or strong) and quan-
tity of stained cells (rare, < 25%, 25-75% or >75%). Simi-
larly to what has been done in the HPA database, values
of the cartesian product of intensity and quantity (i.e.
(negative, rare), (negative, < 25%), (negative, 25-75%), ...,
(strong, > 75%)) have been mapped to natural numbers
belonging to the set {1, 2, ..., 16}. These numbers repre-
sent a score for the protein expression, where 1 is associ-
ated with (negative, rare) and 16 with (strong, > 75%).
Following this operation it has been possible to calculate
average protein expression and to infer protein differen-Mosca et al. BMC Systems Biology 2010, 4:76
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tial expression between breast cancer tissues and normal
tissues as difference between two protein expression
scores.
Systems level data
Considering the molecular systems layer, the G2SBC
Database lists the biochemical pathways (KEGG [16],
Reactome [17] and Gene Ontology (GO) Biological Pro-
cesses (BP) [20]) - with the term "biochemical pathway"
we refer to any type of molecular circuit, i.e. metabolic,
signalling and gene regulatory, since all of them are based
on biochemical processes such as biochemical reactions,
proteins association and dissociation - and PPIs (col-
lected from BioGRID [18]) that complement information
about biochemical pathways.
PPIs data have been used to create a PPIs network that
has been analysed using concepts derived from the graph
theory. In particular, clustering coefficients (a measure of
the neighbourhood density), all-pairs shortest paths (a
shortest path in a graph is the path connecting two verti-
ces such that the sum of the weights of its edges is mini-
mised) and their lengths (the number of edges that
belong to the path) have been calculated. Other interest-
ing information related to molecular systems is repre-
sented by the association of the breast cancer genes with
the cell cycle process (CellCycle Database [19,23]),
including the set of mathematical models available for
this process.
Considering the cellular systems level, the database
includes data about breast cancer types, tissue images
and mathematical models (mostly based on ordinary dif-
ferential equations) available in literature, which focus on
carcinogenesis, tumour growth and tumour response.
Ontologies
To provide a standard framework for data integration and
to enhance a systemic view of breast cancer information,
a rich ontology layer underlies the database structure.
Where available, genes are annotated using the GO and
biochemical pathways by the KEGG Pathway [16] ontol-
Figure 1 Architecture of the G2SBC Database. The G2SBC Database is the result of a multilevel data integration approach. The web interface pro-
vides a query system, a series of tools for the analysis of the contents and a mathematical models section.Mosca et al. BMC Systems Biology 2010, 4:76
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ogy (derived from the hierarchical organisation of KEGG
pathways). This approach not only allows the availability
of a commonly recognised vocabulary, that promotes
data sharing and information querying, but also increases
the performance of statistical and analytical studies.
Indeed, the graphs Gi = (Ni,Ei) (where Ni is the set of
vocabulary terms, Ei is the set of edges between terms and
i identifies a particular ontology), that undergo the hier-
archically structured terms, represent a crucial instru-
ment to shed light on relationships between biological
components, thus performing more accurate queries and
even promoting the deduction of new relations. Ontolo-
gies have been exploited even to better define the scien-
tific context of the developed resource. Human disease
ontology [24], BRENDA tissue ontology [25] and cell type
ontology [26] are included in the ontology section: these
ontologies can be browsed by means of the Ontology
Lookup Service [27], an EBI tool that provides a web ser-
vice interface to query multiple ontologies, and allow the
localisation of a particular element (such as breast cancer,
mammary gland and mammary gland cells) among the
hierarchically organised elements of the same ontology
(human diseases, human tissues and human cell types
respectively).
Utility and Discussion
The web interface of the G2SBC Database (implemented
employing PHP and JavaScript languages), provides a
series of tools to show and analyse data collected in the
resource. An extensive help section is available through
the left side menu of the web site and shows detailed
examples on how to explore the database content and
how to exploit the tools integrated in the resource: use
cases are described for illustrating what kind of predic-
tions are allowed by the G2SBC database.
The web site pages are grouped into three main sec-
tions, listed in the left side menu. The first group con-
cerns the query system, that is structured in the molecular
components, the molecular systems and the cellular sys-
tems level. The second section concerns the data analysis
tools  available through the web interface. This area
includes: the "Neighbourhood density and hubs" and the
Table 1: Number of genes associated with the listed types of molecular alteration
Genome Cell line Clinical
Amplification 25 24
Deletion 5 16
Insertion 2 8
Methylation/Acetylation 18 23
Single Nucleotide Polymorphism 3 21
Transition 14 39
Translocation 3 1
Transversion 16 47
Transcriptome
Expression Level 88 2027
Splice Variant 28 17
Proteome
Activity 8 12
Altered Interaction 16 3
Altered Isoform Splice Variant 10 9
Altered Localisation 9 31
Amino Acid Change 6 31
Deletion 0 2
Expression Level 36 117
Post Translational Modification 13 4
Genes affected by at least one molecular alteration 2238Mosca et al. BMC Systems Biology 2010, 4:76
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"Shortest paths" tools, both relying on the PPIs network
analysis; the gene-annotation enrichment analysis (GEA);
the Blast tool [28], which aligns query sequences against
the data stored in the G2SBC Database. Finally, the web
interface maintains a model oriented section, which
involves two aspects. The first one concerns the interac-
tion among cell cycle regulation and breast cancer: due to
this connection it is possible to retrieve the breast cancer
genes involved in cell cycle control and simulate the asso-
ciated mathematical models. The second regards the
mathematical models related to carcinogenesis, tumour
growth and response to treatments.
The query system
At the molecular components level, it is possible to query
the G2SBC Database through gene or protein identifiers,
synonyms and descriptions, in order to directly retrieve
the breast cancer gene report. In this page users can find
the information related to each gene that has been inte-
grated into the database. This data includes gene and
gene product identifiers, SNPs, molecular alterations
involved in breast cancer, microRNAs, tissue expression,
drugs, molecular interactions established by gene prod-
ucts, molecular pathways regulated by the listed protein
and cell cycle associated kinetic models.
Moreover, it is possible to query the system starting
from information about gene products function, repre-
sented by the protein domains and the GO molecular
functions. An interesting application of this query con-
cerns the knowledge about proteins involved in a key bio-
logical function, which is often under aberrant control in
cancer conditions: transcription regulation. In fact,
through this query, it is possible to list the transcription
factors associated with molecular alterations in breast
cancer.
Another possibility is to query the system considering
the spatial localisation. This information includes the
knowledge related to the gene localisation within the
genome by means of spatial coordinates: in this case, the
G2SBC Database provides the interactive visualisation of
the genome by means of the UCSC Genome browser
[29]. Spatial localisation concerns also the cell environ-
ment, a feature accomplished by using the GO cellular
components annotation. An example is focusing on the
membrane proteins, which play an important role at the
beginning of intracellular signalling cascades and con-
tribute, for instance, to the cancer cells insensitivity to
anti-growth signals.
Molecular alterations
The G2SBC Database contains several types of molecular
alterations associated with breast cancer. These altera-
tions encompass the genome (mutations and SNPs), the
transcriptome (RNA expression level and splicing varia-
tions) and the proteome (protein expression level,
sequence, structure, localisation), as shown in Table 1.
T h e  w h o l e  n u m b e r  o f  g e n e s  a f f e c t e d  b y  a t  l e a s t  o n e
molecular alteration is 2238, approximately the 9%-11%
of the human genes. Due to the wide use of gene expres-
sion microarray technology, almost all of these genes
show at least one alteration regarding the transcriptome.
A lower number of genes present DNA and proteome
variations.
The list of alterations associated with a particular gene
is available in the gene report. Each alteration is anno-
tated through some features - that vary according to the
type of molecular alteration - such as the contig number,
the direction of gene expression variation (up/down), the
experimental method used, the cancer type or the cell
line. Lastly, each molecular alteration is reported along
with the reference to the paper where its experimental
identification has been described.
Biochemical pathways and breast cancer genes
Considering the molecular systems layer, it is possible to
query the G2SBC Database starting from a specific bio-
chemical pathway name, exploiting data from KEGG,
Reactome and GO BP. This system level query follows a
top-down approach, which leads to the "building blocks"
starting from the systems. In this context, the user inter-
ested in a particular biological process can retrieve the
list of genes that may affect its normal activity leading to
cancer conditions. An example is the response to lowered
oxygen tension, an important process for tumour pro-
gression; searching through the keyword "hypoxia" it is
possible to understand that the GO BP term "response to
hypoxia" includes 30 genes which have at least one evi-
dence of association with breast cancer.
Breast cancer types
For what concerns the information that can be retrieved
from cellular and tissue levels, the query system lists a
series of breast cancer types (e.g. ductal, lobular, medul-
lar) and subtypes (e.g. ErbB2 positive, estrogen receptor
positive). A specific breast cancer type can be selected in
order to obtain the list of genes products (i) found
expressed in the considered breast cancer type according
to the HPA data and/or (ii) associated with molecular
alterations identified in the selected breast cancer type.
Breast cancer types supported by HPA data are pro-
vided with information concerning protein differential
expression with respect to the normal tissue, Figure 2. For
each protein, the number of tissue images where it has
been up-/down-regulated or where it does not change is
reported. This information has been integrated with
KEGG Pathways: for each pathway, the number of the
proteins, (i) that are up-regulated in the selected breast
cancer, (ii) that show a similar expression level with
respect to the normal tissue, (iii) that are down-regulated
in the selected breast cancer, is reported. These data can
be easily visualised by following the link provided toMosca et al. BMC Systems Biology 2010, 4:76
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KEGG maps images, where proteins are automatically
highlighted using distinct colours, according to their
expression (i.e. red indicates up-regulation while green
indicates down-regulation).
In this context, the multilevel data integration realised
by the G2SBC Database provides some insights on the
characterisation of the different breast cancer types in
terms of genes and biochemical pathways.
Ontologies improve the search of database content
Other than representing an important instrument for
generating new hypotheses and producing novel knowl-
edge [30], the ontology layer which underlies the database
structure improves the user capability of browsing data,
due to the available standardised terms and the connec-
tion map provided by the ontology tree. GO terms and
KEGG pathways are browsable through a section where
the GO directed acyclic graph and the KEGG pathways
hierarchy tree are available. Moreover, breast cancer
genes have been mapped to the GO terms and the KEGG
pathways: hence, it is possible to examine the number of
breast cancer genes associated with each molecular func-
tion, cellular component, biological process and KEGG
pathway. By querying all the genes associated with a spe-
cific GO term, it is possible to retrieve even the genes
associated with terms that present an "is a" relationship
with the initial one. For example, selecting the "damaged
DNA binding" molecular function, both the terms "oxi-
dised DNA binding" and "alkylated DNA binding", which
describe particular types of damage, are retrieved thanks
to the ontology layer.
G2SBC Database embedded tools
The G2SBC Database provides a series of tools which can
be used to analyse the database content. By means of the
sequential use of these tools it is possible to create analy-
sis pipelines, which in some cases can lead to new predic-
tions.
Neighbourhood density, hubs and shortest paths
G2SBC Database web interface provides two tools that
rely on the application of the graph theory to biological
networks.
The first tool retrieves breast cancer genes that have a
particular neighbourhood density in the PPIs network
and establish a specific number of interactions. On one
hand, a protein with a high neighbourhood density, mea-
surable by means of the so called clustering coefficient, is
potentially part of a protein complex [31] and, more gen-
erally, this feature may indicate that it belongs to a group
of proteins that cooperate for a specific cell function. For
instance, this is the case of the highly connected protein
Figure 2 Integration between protein expression in different breast cancer types and biochemical pathways data. A use case showing the 
differential expression of some proteins belonging to the "adherens junction" KEGG map in lobular carcinoma in situ and invasive lobular carcinoma 
tissues images collected from the HPA database. Green: down-regulation; yellow: similar expression.Mosca et al. BMC Systems Biology 2010, 4:76
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Polr2f (RNA polymerase II, polypeptide F), which estab-
lishes physical interactions with four polypeptides
belonging to the RNA polymerase II and five subunits of
the mediator complex, which is a co-activator involved in
the transcription of nearly all RNA polymerase II-depen-
dent genes [32]. On the other hand, proteins presenting a
high number of interactions act as hubs in the PPIs net-
work. These proteins represent elements which play an
important role for the integrity of the network and are
often associated with potential weak spots for cell func-
tions [33]. The G2SBC Database allows the user to focus
on hub proteins for which literature evidences of associa-
tion with breast cancer are available.
The second tool concerns the "Shortest paths analysis",
which is particularly useful in systems biology since it
enables the reconstruction of biochemical pathways (an
example of the use of shortest paths for the reconstruc-
tion of metabolic networks can be found in [34]). The
G2SBC Database provides a tool for calculating the short-
est path in the PPIs network between two breast cancer
proteins. The result of this calculation is a table that lists
the proteins belonging to the path and the biochemical
pathways in which they are involved. This integration
enables the user to clarify the relationships between
breast cancer genes on the basis of the molecular systems
in which they are included. For instance, this tool shows
that proteins encoded by the genes CCND1 (cyclin D1)
and EGFR (epidermal growth factor receptor), both asso-
ciated with breast cancer, have a distances on the PPIs
equal to 2, due to their common interacting partner
STAT3 (signal transducer and activator of transcription
3). Moreover, it is possible to observe that all the three
proteins have been annotated as members of the "Path-
ways in Cancer" map of KEGG Pathway.
Gene-annotation enrichment analysis (GEA) enables the 
query result characterisation
The G2SBC Database provides a tool for GEA. The appli-
cation finds the set of annotations associated with the
input gene set. Each annotation term is coupled with a P
value (calculated through the appropriate cumulative
hypergeometric distribution) indicating the probability of
obtaining the observed distribution of terms among the
whole gene set in a hypergeometric experiment. This
measure identifies annotation terms that are significantly
enriched in a specific gene set. These terms represent dis-
tinctive properties of the gene set and constitute the
starting point for further functional characterisation. The
GEA tool is integrated in the web interface of G2SBC
Database and is available whenever a gene list is obtained.
Results can be downloaded in a text file. For instance, by
performing an appropriate query on the clustering coeffi-
cients and the number of interactions, the user discovers
that the protein inhibin, encoded by the gene INHBC, is
part of a highly interconnected module of proteins which
involves the activins (ACV proteins), as shown in Figure
3. Both inhibins and activins are growth factors involved
in cell differentiation and proliferation [35]. By running
the GEA tool on the set of proteins involved in the mod-
ule the user can find, for example, that terms like "TGF-
beta signalling pathway" and "cytokine-cytokine receptor
interaction" have significant P values and, hence, these
terms represent the annotation signature that character-
ises the gene set.
It is worth noting that the GEA tool is useful whenever
the selected breast cancer gene is poorly annotated. In
this case, the tool provides a way to study the annotations
of its interacting partners and gain some insights, accord-
ing to the concept of network-based function prediction
[36] (the closer the proteins in the PPIs network, the
higher the functional similarity). For example, the gene
DCN (decorin) is currently associated with two GO BP
terms: a very general term, "organ morphogensis", and
"peptide cross-linking via chondroitin 4-sulfate gly-
cosaminoglycan". The GEA tool indicates that DCN pro-
tein interacting proteins regulate "collagen fibril
organisation" (P value 3.66E-8), "skin morphogenesis" (P
value 4.46E-06), "skeletal system development" (P value
8.02E-6), a series of annotations which suggest more
detailed biological roles of DCN. Another case is repre-
sented by the gene MTA1 (metastasis associated 1), that
is currently annotated with two general GO BP terms:
"regulation of transcription, DNA-dependent" and "signal
transduction". The analysis of MTA1 protein neighbours
shows that it interacts with proteins that regulate "histone
deacetylation" (P  value 2.253E-5), "nucleotide-excision
repair, DNA damage removal" (P  value 6.05E-5) and
"chromatin modification" (P value 8.89E-5), that are all
processes related to the DNA transcription.
SNP mutation structural modelling
For each SNP annotated in a breast cancer gene exon,
which leads to missense in the corresponding protein, a
pipeline aimed at modelling the macromolecule with the
allele variant is available. In detail, the gene report pro-
vides an application that shows the gene structure where
the annotated SNPs in the CDS (coding DNA sequence)
are highlighted. By selecting the desired SNP, the web
interface lists the IDs of the available PDB structures
whose chains contain a model of the wild type sequence
associated with the selected allele variant. The user can
choose one chain and the complete structure is automati-
cally downloaded from the PDB web site. Starting from
this PDB structure, the polymorphic model is created
using an automatic approach based on a customised
python script from Modeller [37]. It replaces the side
chain of the polymorphic residue in the PDB file and
optimises the conformation by energy minimisation and
molecular dynamics. After the computation, the PDB for-Mosca et al. BMC Systems Biology 2010, 4:76
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matted structure with the polymorphic residues high-
lighted is provided through the web interface.
Genes distribution among breast cancer types
This tool provides a statistical approach to tissue-related
information. Tissue data maintained in the database,
which allows vertical integration among proteomic and
cellular levels, are analysed by considering the association
between genes and breast cancer types. By means of the
data collected in the HPA, we calculated the frequency of
detection of a specific gene product among the breast
cancers types, in order to show its distribution over them.
This content is shown in a dedicated web page reachable
from the gene report, where the list of the antibodies
exploited to detect the specific gene product is provided,
together with a pie-chart plot which visualises the calcu-
lated percentage distribution.
Mathematical models
Since the cell cycle process is often affected by misregula-
tions that can lead to cancer onset [1], the G2SBC Data-
base has been coupled with the CellCycle Database. In
particular, using the G2SBC Database it is possible to
obtain the list of breast cancer genes that play a role in the
cell cycle process and which take part in the mathemati-
cal models that describe the dynamics of this process in
terms of temporal evolution of protein concentrations.
This integration enables the analysis of cell cycle dynam-
ics in breast cancer conditions according to the reported
molecular alterations. The simulation of cell cycle models
is run from the CellCycle Database web site. For instance,
according to some evidences reported in the literature
[38-40] and available in the G2SBC Database, the cell
cycle gene corresponding to cyclin D has been found
over-expressed in breast cancer cells. An example of this
analysis, based on the cell cycle model described in [41],
Figure 3 An example of analysis in which the G2SBC Database tools are combined. a) Query based on the clustering coefficient of breast cancer 
proteins in the PPIs network. I) One row of the results: the breast cancer gene INHBC has a high clustering coefficient (0.8) and establishes 6 interactions 
(degree). c) INHBC along with the genes in its first neighbourhood in the PPIs network are submitted to the GEA tool (only part of the results are 
shown).Mosca et al. BMC Systems Biology 2010, 4:76
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is presented in Figure 4. The entrance in the cell cycle S
(synthesis) phase is represented through the dynamics of
both the transcription factor E2F and cyclin E. In order to
simulate the pathological state described in the G2SBC
Database (cyclin D overexpression), it is possible to select
the model (Figure 4a) and initialise it with a higher value
of the cyclin D initial concentration. The computed
dynamics reveals an earlier and faster entrance in the S
phase, represented by a higher concentration of both the
transcription factor E2F and cyclin E with respect to the
normal state (Figure 4b,4c). 
Moreover, some mathematical models related to breast
cancer development and response to treatment have been
encoded in the Systems Biology Markup Language
(SBML) [42] in order to allow their simulation in the ded-
icated section of the G2SBC Database. For instance, in
the model by Spencer et al. [43] the multistep process
which describes the transformation of a normal cell into a
cancer cell through the acquisition of mutations is
encoded in a set of ordinary differential equations; so
doing, the model explores the role of angiogenesis, cell
death rates, genetic instability, and replication during the
cancer development. In the model section of the G2SBC
Database it is possible to get general information about
the mathematical models, and to access the abstracts of
the articles where the models have been presented to sci-
entific community. In this section, users can also explore
the mathematical formalisation, simulate the model
dynamics with respect to time, plot and download the
simulations results.
Conclusions
The G2SBC Database is a freely available resource devel-
oped with the aim of supporting research on breast can-
Figure 4 Differential dynamics of a cell cycle ODE model [41] in normal and cancer states. a) List of the cell cycle models that involve the cyclin 
D, which is often over-expressed in breast cancer cells; the model chosen for the simulation is indicated by the blue arrow. I) Normal cell cycle dynam-
ics are characterised by a timed activation of the transcription factor E2F and the following activation of cyclin E in its active form (CycEa). c) Breast 
cancer state: according to the breast cancer associated up-regulation of cyclin D, its synthesis rate is increased, determining an earlier entrance into 
the S phase, with the early activation of the transcription factor E2F from which the cyclin E synthesis depends; such events determine a faster cell 
cycle progression allowing a more efficient tumour proliferation.Mosca et al. BMC Systems Biology 2010, 4:76
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cer in a systems biology context. Using data integration a
large amount of records have been collected in this data-
base: therefore, enhanced query solutions and web tools
are provided to infer non trivial knowledge, e.g. the pro-
teins differentially expressed in each breast cancer type.
The contents and tools provided encompass molecular
components, molecular systems and cell systems layers.
The G2SBC Database provides systems level queries
(enabling a top down approach), tools based on PPIs net-
work (e.g. the shortest paths) and a mathematical models
section. Due to these features, it is possible to overcome
the limits of a resource dedicated only to data explora-
tion, enabling predictions that may induce new experi-
ments.
The G2SBC Database will be periodically updated
according to the publication of new research, biological
data and mathematical models about breast cancer. We
plan to integrate data from other sources, e.g. the Human
Protein Reference Database (HPRD) [44] , and to enrich
the mathematical model section. Moreover, we want to
extend the system in order include data about M. muscu-
lus and R. norvegicus, making cross-species comparisons
possible.
Availability and requirements
The G2SBC Database is freely available at the URL http://
www.itb.cnr.it/breastcancer.
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